Our Oncology lead, Siobhan Davies has an exciting Oncology podcast to share based on ESMO 2021 big topics and highlights. She explores whether checkpoint inhibitors should be part of neoadjuvant treatment in TNBC and NSCLC and developments in cervical cancer – a real game changer. Not only that, but she shares our views on the big topics in the area of Oncology.